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Objective: The extraarticular symptoms are important in the pattern differentiation of traditional Chinese medicine 
(TCM), and the present study is designed in an attempt to find the associations between the extraarticular symptoms 
and American College of Rheumatology (ACR) Response in 194 cases of rheumatoid arthritis (RA) treated with 
biomedicine. 
Methods: The data were obtained from a randomized clinical trial. One hundred ninety-four RA patients were 
treated with the biomedical therapy (diclofenec, methotrexate and sulfasalazine). ACR20 response in 24 weeks was 
used for the efficacy evaluation. Eighteen symptoms (including 13 extraarticular symptoms) that TCM practitioners 
focus on were collected for exploration on the association between the symptoms and the efficacy of the biomedical 
therapy with association rules method. 
Results: After 24 weeks, a total of 135 patients receiving biomedicine had achieved an ACR20 response. The 
association rules analysis on each symptom showed that soreness in the waist was more associated with ACR20 
response, but with lower support (selected sample size based, 20.10% and 14.95% respectively); cold intolerance 
and cold joint were found to be associated with ACR20 response with higher support (48.97% and 53.61% 
respectively), and the confidences (predicted effective rate) were 73.08% and 71.23% respectively. The associations 
between combination of symptoms (among them, there was at least one extraarticular symptom) and ACR20 
response indicated that cold intolerance or cold joint with higher confidence and support were the most important 
extraarticular symptoms. 
Conclusion: The RA patients with “cold intolerance” and “cold joints”, which are the extraarticular symptoms that 
TCM practitioners focus on, may show higher ACR20 response when treated with the biomedical approach. 
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Rheumatoid arthritis (RA) is a long-term disease that 
causes inflammation of the joints and surrounding tissues, 
leading to a wide variety of symptoms and signs.1 The 
symptoms in RA are diversified, and can be basically 
classified into the articular and extraarticular ones. The 
extraarticular symptoms, such as depression, are 
associated with inflammation and appear to have 
independent effects on perceived pain in rheumatoid 
arthritis.2 While more extraarticular symptoms, such as 
intolerant to cold and cold joint, are considered to be 
most important evidence for Traditional Chinese 
medicine (TCM) pattern differentiation (similar to 
diagnosis in biomedicine), which guides TCM therapy in 
the treatment of disease.3 The authors’ previous study 
showed that TCM pattern differentiation based on the 
symptoms can help identify a subset of rheumatoid 
arthritis patients that will more likely respond to bio- 
medical therapy,4 though TCM pattern differentiation is 
hard to be understood by biomedical scientists. Using 
statistical tools and modeling techniques, the interesting 
and hidden rules in the data may be found, and the 
association rules is one of the important data mining 
tasks which can reveal the relationships among different 
items .5-7 In this paper, the authors applied the standard 
data mining technique of the association rules as a basis 
to explore the clinical trial data on RA patient in order to 
show the influence of extraarticular symptoms on 
ACR20 response in the treatment with the biomedicine 
approach. 
METHODS1 
Study Design  
This multicenter, randomized, single-blind (patients were 
unaware of detailed therapy) study, in which the 
assessors (rheumatologists) blinded, was conducted at 9 
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centers in China. The primary endpoint was ACR 20 in 
24 weeks. More details about the clinical trial have been 
reported previously.8 
Inclusion Criteria  
Men and women, aged from 18 to 70 years, were eligible 
to participate if they met the American College of 
Rheumatology (ACR) criteria for RA, with disease 
duration at least for one year, and the illness condition 
categorized as Class I, II, or III under ACR guidelines.9 
Patients who agree to sign an informed consent were 
obtained. 
Exclusion Criteria  
The patients with severe cardiovascular, lung, liver, 
kidney, hematologic or mental disease, and women who 
were pregnant, breast-feeding or were planning to be 
pregnant in the following 8 months were excluded. 
Sample Size Determination 
The sample size was established by comparing the rates 
of validity between TCM and Western medicine. In 
reviewing the literature, the sample size can be 
calculated by the estimated value of the rate of validity 
for the formula, 91.11% in the TCM group and 79.00% 
in Western medicine group (set Į=0.05, ȕ=0.10). Sample 
size was 201 in both groups. And with a dropout rate for 
follow up as 20%, the sample size for each group was 
241 and 482 in the two groups.  
Randomization 
The patients were randomized by computer using the 
SZS-12 PRCO PLAN system (Version 6.12 for Win- 
dows). The details of the allocation sequence were in a 
sealed envelope and unknown by the study investigators 
and the participants. Randomization was designed so that 
each participant would have a 50% chance of assignment 
to one of the two groups, and each participant had their 
own unique code number. Only this number was used to 
identify the patients’ Case Report Form.  
Blinding 
As for the different interventions in the trial, some drugs 
have adverse reactions (such as the effect of Tripterygii 
totorum on the reproductive system). Case group 
division is adapted to single-blind method with the 
therapeutic effects and side effects evaluated by an 
independent third party. The study was approved by the 
Ethical Research Committee, Guangdong Provincial 
Hospital of Traditional Chinese Medicine. Informed 
consent was obtained from each patient. 
Procedures 
From February 1997 to November 1997, a total of 522 
patients were enrolled into the study. Of these 522 
patients, 489 qualified for the clinical study and 437 
patients complete the follow up. (Flow Chart 1).
 
 
Flow Chart 1. Number and reasons for patients not completing the study. 
522 screened 
33 excluded: 
--21 exclusion criteria 
--12 refused to participate 
489 randomized 
247-TCM group 242 -WM group 
29 discontinued 
   13 lack of efficacy 
   6 adverse events 
   8 patients withdrew 
   2 other reasons 
23 discontinued 
   5 lack of efficacy 
   6 adverse events 
   9 patients withdrew 
   3 other reasons 
218 completed 24 weeks 219 completed 24 weeks 
No one included in this analysis 194 included in this analysis (complete data) 
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Trial Profile  
Fifty-seven patients withdrawn from the study, 18 due to 
poor efficacy, 17 according to their request, 5 for other 
reasons (change job; attending training classes and 
starting a new job) and 17 because of adverse effects. 
None of the adverse effects was serious. Of the 437 
patients who completed the follow-up, 41 patients who 
did not receive laboratory examination were not included 
in the PPSA and X-ray analysis. One hundred ninety-four 
patients in WM group with a Disease Activity Scores 
that include different 28-joint (DAS28-3) score of higher 
than 2.6 were admitted into statistical analysis. 
Interventions 
Patients in Western medicine-treated group: Biomedical 
combination therapy using both the nonsteroidal anti- 
inflammatory drugs (NSAIDs) and the disease modifying 
anti-rheumatic drugs (DMARDs). Diclofenec (extended 
action 75 mg tablet) as the NSAID was orally taken once 
a day after a meal till the acute inflammation was con- 
trolled. The DMARDs used were Methotrexate (MTX) 
and Sulfasalazine (SSZ). MTX was orally taken once a 
week at a starting dosage of 5 mg with addition of 2.5 
mg each week up to 15 mg, and a maintenance dosage 
from 2.5 mg to 7.5 mg. SSZ was orally taken twice a day 
from a starting dosage of 0.25 g with the addition of 0.25 
g each week, to a maintenance dosage of 0.5 g to 1 g, 
four times a day. 
Measurements 
In the 12th week and the 24th week, the ACR20 was re- 
corded and used for the evaluation of efficacy.9 Efficacy 
evaluation was done by a third party (rheumatologists at 
each center) who did not know the biomedical com- 
bination therapy. 
Within 14 days before randomization, a complete phy- 
sical examination, medical history, and assessment of 18 
symptoms (joint pain, joint tenderness, joint swelling, 
joint stiffness, cold intolerance, soreness in the waist, 
frequent urination at night, hot joint, thirsty, fatigue, 
dysphoria, cold limbs, vexation, fever, weakness in the 
waist, dizziness, turbid urine in yellow color, numb 
heavy limbs) typically evaluated by TCM physicians 
were performed and recorded. 
Only patients treated with the biomedical combination 
therapy were included for analysis in this study. Disease 
activity was assessed by DAS28-3. Only patients with a 
DAS28-3 score higher than 2.6 were admitted into 
statistical analysis.  
Safety Analyses 
Five hundreds and ten patients were included in the 
Safety analyses.  
Role of the Funding Sources 
This study was supported by the National Key Project of 
the 10th Five-Year Plan. The funding sources had no role 
in study design; collection, analyses, and interpretation 
of all data; writing the article; and the decision to submit 
the manuscript for publication. 
Statistics  
Sample size for this study was calculated based on an 
estimate for TCM response rate of 91.11% and WM 
ACR20 response rate of 79.00% referring to previous 
clinical literature. The sample size calculation was 
performed using the formula of proportions under the 
assumption of a two-tailed test with 80% power and an 
alpha level of 0.05. The required sample size was 
therefore 201 cases in each group. The sample size was 
increased to 241 in each group to allow for withdrawals.8 
Association rules on SAS 9.1 Enterprise Miner statistical 
package (Order No. 195557) were used. In this study, the 
symptoms (including some signs such as joint swelling) 
were set as items. In order to clarify the rules, the 
definitions for Support and Confidence are described 
with the following examples: 
Suppose the {item: symptom A} ==> Effective as 
association rule, 39 patients with symptom A have effect, 
194 patients got biomedical combination therapy, then 
the Support is 39/194 = 20.10%. 
Suppose the {item: symptoms A} ==> Effective as 
association rules, 28 patients (responsive case number) 
with symptom A have effect, total 47 patients with 
symptom A, then the Confidence is 28/47 = 82.98%. 
Suppose the {item: symptoms A & symptoms B} ==> 
Effective as association rules, which means that the 
patients with both symptom A and symptoms B have 
effect, the Confidence and Support will be as described 
above. 
A Chi-Square test is conducted to determine whether the 
baseline data (gender, age) for RA patients with the 
symptoms related to 11 association rule are statistically 
different from what was expected as compared to RA 
patients without the symptoms related to 11 association 
rule, which determines whether the implementation 
(explore the patients with some symptom or symptoms 
combination) was successful due to process imp- 
rovements or to chance.  
Then, the therapeutic efficacy in 194 RA patients with or 
without the symptoms related to 11 association rules 
were compared with Chi Square analysis. A Chi-Square 
test is conducted to determine whether efficiency for the 
sample group (with the symptoms related to association 
rule, rule = 0) are statistically different from what was 
expected as compared to the group (without the 
symptoms related to association rule, rule = 1). The goal 
is to have a P-value that is less than 0.05, which means 
that there is a less than 5% probability for the results that 
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could have been produced by chance.  
RESULTS 
ACR Efficacy Evaluation 
Of the 522 patients who underwent randomization, 21 
patients were excluded as not meeting the inclusion 
criteria, and 12 patients were excluded by refusing to 
participate. 489 were included in the trial, 247 in TCM 
group, and 242 in biomedical combination therapy group. 
Baseline characteristics were similar between the 
treatment groups.8 Thirty-eight patients in the biomedical 
combination therapy group dropped out, and a total of 
194 patients received for 24 weeks. All the 194 patients 
treated with the biomedical combination therapy were 
analyzed. ACR20 response in the 12th week was 36.08%, 
and ACR20 response in the 24th week was 69.59% 
(Figure 1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. ACR response in RA patients treated with the 
biomedical combination therapy for 12 weeks and 24 
weeks. 
Association between ACR20 Response and the 
Extraarticular Symptoms  
The associations between ACR20 response and single 
extraarticular symptom were analyzed (rule 1 in Table 1), 
and the associations between ACR20 response and 2 or 3 
combination (of 2 or 3 symptoms) at least including one 
extraarticular symptom) were analyzed (rule 2 to 11 in 
Table 1). 
The first 1 association rule in Table 1 indicated that, with 
more than 80% confidence, soreness in the waist was 
more associated with effectiveness. However, the RA 
patients did not often show single soreness in waist (with 
support of 20.10%). Cold intolerance and cold joint were 
found to be associated with ACR20 response with higher 
support (48.97% and 53.61% respectively), and the 
confidences were 73.08% and 71.23% respectively. Thus 
the associations of two or three symptoms with ACR20 
response were further explored. From the rule 2 on in 
Table 1, all rules indicated that cold intolerance or cold 
joint were the most important extraarticular symptoms, 
and the ACR 20 response in the cases with diagnostic 
related articular symptoms combined with these two 
extra- articular symptoms would be higher than 69.59% 
(ACR20 response in all 194 patients). 
The baseline characteristics (gender, age) showed no 
significant differences between patients with and without 
one association rule. The of Chi-Square tests represented 
the therapeutic efficacy in 194 RA patients all showed 
significant differences between patients with or without 
symptoms related to 11 association rules (Table 2).
Table 1. Association rules obtained from the symptoms of RA and ACR response with biomedical combination therapy 
No. Association rule Support (%) Confidence (%) Responsive case number 
1 {Soreness in waist}==> Effective 20.10 82.98 39 
2 {Cold intolerance, Joint stiffness & Joint pain}==> Effective 20.62 93.02 40 
3 {Cold intolerance, Joint stiffness & Cold joints} ==> Effective 20.10 90.70 39 
4 {Cold intolerance & Joint stiffness} ==> Effective 21.65 87.50 42 
5 {Cold intolerance & Joint swelling} ==> Effective 20.62 86.96 40 
6 {Cold intolerance, Joint tenderness & Joint pain} ==> Effective 27.32 82.81 53 
7 {Cold intolerance & Joint pain} ==> Effective 32.99 82.05 64 
8 {Cold intolerance, Joint pain & Cold joints} ==> Effective 30.41 81.94 59 
9 {old intolerance & Joint tenderness} ==> Effective 30.93 78.95 60 
10 {Cold intolerance, Joint tenderness & Cold joints} ==> Effective 28.35 78.57 55 
11 {Cold intolerance & Cold joints} ==> Effective 45.36 75.21 88 
Notes: {A} ==> B means that A is more likely associated with B. The Support is the percentage of responsive cases with the symptom in the 
total treated cases. The Confidence is the percentage of responsive cases with the symptom in the total cases with the symptom. The ACR20 
response after treatment with biomedicine for 24 weeks was 69.59% (in total 194 cases) and the rules with Confidence >70% were included. 
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Table 2. Therapeutic efficacy in 194 RA patients with or without symptoms related to the 11 association rules 
No. Association rule Symptom Total Effective (%) P value 
0 147 65.31 1 {Soreness in waist} ==> Effective 
1 47 82.98 
0.0219* 
0 151 62.91 2 {Cold intolerance, Joint stiffness & Joint pain} ==> Effective 
1 43 93.02 
0.0002* 
0 151 63.58 3 {Cold intolerance, Joint stiffness & Cold joints} ==> Effective 
1 43 90.70 
0.0006* 
0 146 63.70 4 {Cold intolerance & Joint stiffness} ==> Effective 
1 48 87.50 
0.0019* 
0 148 64.19 5 {Cold intolerance & Joint swelling} ==> Effective 
1 46 86.96 
0.0034* 
0 130 63.08 6 {Cold intolerance, Joint tenderness & Joint pain} ==> Effective 
1 64 82.81 
0.0050* 
0 116 61.21 7 {Cold intolerance & Joint pain} ==> Effective 
1 78 82.05 
0.0020* 
0 122 62.30 8 {Cold intolerance, Joint pain & Cold joints} ==> Effective 
1 72 81.94 
0.0041* 
0 118 63.56 9 {Cold intolerance & Joint tenderness} ==> Effective 
1 76 78.95 
0.0230* 
0 124 64.52 10 {Cold intolerance, Joint tenderness & Cold joints} ==> Effective 
1 70 78.57 
0.0410* 
0 77 61.04 11 {Cold intolerance & Cold joints} ==> Effective 
1 117 75.21 
0.0358* 
Notes: Symptom 0=patients with this symptom or symptom combination; Symptom 1= patients without this symptom or  
symptom combination. *P<0.05 
DISCUSSION 
The previous study showed that biomedicine therapy was 
better in treating RA with TCM cold pattern.8 However, 
it is really hard for biomedical scientists to understand 
the meanings of TCM pattern classification, even harder 
to understand all the TCM focused extraarticular 
symptoms. Therefore, it would be important to find out 
the influence of the common TCM focused extraarticular 
symptoms on the efficacy in the treatment of RA, with 
the indication and specification for the biomedicine 
therapy. In the present study, two extraarticular 
symptoms, that is cold intolerance and cold joint, were 
found to be related to ACR20 response for the 
biomedical combination therapy. 
Data mining is a technique for discovering the useful 
information from large databases. A large database 
represents a huge amount of information which can be 
potentially very useful if extracted and summarized 
correctly, and using the statistical tools and modeling 
techniques, one can discover the interesting and hidden 
patterns in the data.5,6 Here, the authors applied the 
standard data mining technique of association rules as a 
basis to explore the patients’ data. Association rule 
mining is one of the important data mining tasks which 
may reveal the relationships among different items.7 
Association rule mining technology is being currently 
used by a number of medical fields, including gene, 
clinical, and so on.10,11 Thus, the authors think it would 
be suitable to apply this approach to explore the 
influence of the symptoms TCM concerned and ACR20 
response. In this paper, the writers used the analysis to 
explore each of the symptoms and the symptom 
combinations, and found that cold intolerance and cold 
joint were the most important symptoms associated with 
the efficacy.  
But how to set proper minimum confidence to 
association rule mining algorithm is a very important 
issue in applying association rule mining. The 
association rules are considered interesting if they satisfy 
both a minimum support threshold and a minimum 
confidence threshold. Such thresholds can be set by users 
or domain experts but not a common criterion. There is 
no general rule to set a proper minimum threshold and 
the only thing the authors can do is setting minimum 
threshold by their experience and by characteristic of 
database. The professional experience includes the 
relationship between the symptoms and diseases based 
on TCM theory. Furthermore, all the 194 patients treated 
with the biomedicine were analyzed, and the ACR20 
response in the 24th week was 69.59% (Figure 1). The 
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authors use data mining in order to explore patient with 
some combination of symptoms will get higher response. 
If the writers set higher threshold, they may get too less 
association rules, so they set minimum confidence as 
70% and get 11 rules. The authors considered that these 
11 rules could be used for the further discussion but not 
too much. In this study, the hypothesis is that, given 
association rules that capture the characteristics of 
patients. Then, the authors test the therapeutic efficacy in 
194 patients whether have significant differences 
between patients with or without symptoms related to the 
11 association rules that they have captured. That means 
the therapeutic efficacy in patients with different 
characteristics is different. And the authors will verify 
their hypothesis by carrying out next clinical trials and 
other methods.  
It has been proved that one of the important symptoms 
for TCM pattern differentiation could influence the 
efficacy of therapies,2 and that some extraarticular or 
manifestations, such as inflammatory responses in other 
organs, may lead RA into different progressive way that 
need different therapeutic approaches.12 In TCM, all the 
symptoms and signs (including tongue appearance and 
pulse feeling, which will not be discussed here because 
of their complexity in understanding from the view of 
biomedicine), especially those extraarticular symptoms 
which exist widely in RA patients but not emphasized by 
biomedicine, are the important information for TCM 
pattern differentiation. The previous results showed that 
RA patients with some specific extra-articular symptom 
or symptom combination could be treated in more 
efficient way with a therapeutic method of either 
biomedicine or TCM.3 And the results supported that the 
efficacy of biomedical combination therapy would be 
better if only used in the RA patients with cold 
intolerance and cold joint. Few of the rheumatologists 
care about the extraarticular symptoms in clinical 
practice in biomedicine, but the TCM doctor does care 
about it. The writers’ findings indicate that some 
extraarticular symptoms should be taken into 
consideration for the indication and specification of a 
therapy or an anti-rheumatic drug. 
The RA patients with intolerance to cold and cold joints, 
which are the extraarticular symptoms focused by TCM, 
may show higher ACR20 response when treated with the 
biomedical approach. The results further suggested that 
the extraarticular symptoms that TCM practitioners focus 
on would be useful for specifying the indication of the 
biomedicine therapy. 
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